Manuel Campos
13Patents
6h-index
25Co-inventors
66Inventor score
Filing activity: Apr 24, 1989 → Apr 27, 2015
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5503833A | VP6 encapsulated drug delivery | Chemistry; Metallurgy | 17 | Expired |
| US5273889A | Gamma-iterferon-leukotoxin gene fusions and uses thereof | Emerging Cross-Sectional Technologies | 16 | Expired |
| US5238823A | Interleukin-2-leukotoxin gene fusions and uses thereof | Chemistry; Metallurgy | 14 | Expired |
| US5594107A | Chimeric protein comprising an RTX-family cytotoxin and interferon-2 or interferon | Emerging Cross-Sectional Technologies | 13 | Expired |
| US6270800A | Aqueous solvent based encapsulation of a bovine herpes virus type-1 subunit vaccine | Emerging Cross-Sectional Technologies | 9 | Expired |
| US6713071B1 | Proteins from actinobacillus pleuropneumoniae | Human Necessities | 7 | Expired |
| US6096320A | Vaccines with chimeric protein comprising gamma-interferon and leukotoxin derived from pasteurella haemolytica | Emerging Cross-Sectional Technologies | 4 | Expired |
| US6787146B2 | Neospora vaccine | Emerging Cross-Sectional Technologies | 3 | Expired |
| US6911206B1 | Fusion proteins comprising carriers that can induce a dual immune response | Chemistry; Metallurgy | 3 | Expired |
| US5049378A | Prevention and treatment of porcine haemophilus pneumonia (PHP) | Human Necessities | 1 | Expired |
| US5431899A | Rotavirus VP6 as a diagnostic and targeting agent | Emerging Cross-Sectional Technologies | 1 | Expired |
| US9046528B2 | Cross-reactive determinants and methods for their identification | Physics | 0 | Active |
| US10261092B2 | Cross-reactive determinants and methods for their identification | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.